Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03985410 Completed - Clinical trials for Acinetobacter Baumannii-calcoaceticus Complex Infections

Study Evaluating the Effect of ETX2514 on Cardiac Repolarization in Healthy Male or Female Volunteers

Start date: May 23, 2019
Phase: Phase 1
Study type: Interventional

This study is being conducted to evaluate the effects of supratherapeutic ETX2514 plasma concentrations on the heart rate-corrected QT interval (QTc).

NCT ID: NCT03985046 Completed - Clinical trials for Esophageal Squamous Cell Carcinoma

Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC

Start date: October 10, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to observe and evaluate the efficacy and safety of A sintilimab plus chemotherapy followed by definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.

NCT ID: NCT03985007 Completed - Clinical trials for Acute Myeloid Leukemia, Relapsed, Adult

CDIAG Regimen in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Start date: January 1, 2018
Phase: Phase 2
Study type: Interventional

This study is to investigate the therapeutic efficacy and side effect of chidamide, decitabine combined with priming IAG regimen for relapsed or refractroy acute myeloid leukemia

NCT ID: NCT03984279 Completed - Clinical trials for Body Interventional procédures With CT

Comparison of Sequential Fluoroscopy Guidance With Spiral Guidance in Terms of Safety, Effectiveness, Speed and Radiation in Interventional Chest-abdomen-pelvic Procedures

APIR-TDM
Start date: January 17, 2018
Phase:
Study type: Observational

The purpose of the study was to compare sequential fluoroscopy guidance with spiral guidance in terms of safety (number of major complications), effectiveness (number of targets reached), speed (procedural time) and radiation (DLP) in interventional chest-abdomen-pelvic procedures.

NCT ID: NCT03984188 Completed - COPD Clinical Trials

Effectiveness of Low-Dose Theophylline for the Management of Biomass-Associated COPD

Start date: February 23, 2021
Phase: Phase 3
Study type: Interventional

Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, and over 90% of COPD-related deaths occurring in low- and middle-income countries (LMICs). Household air pollution (HAP) - from burning solid fuels such as wood, dung, agricultural crop waste, and coal for energy - is the primary risk factor for COPD in these settings. Biomass-related COPD has a distinct histopathology, phenotype and inflammatory profile when compared to tobacco mediated COPD. Despite the high global burden of biomass-related disease, little is known about the effectiveness of pharmacotherapies for biomass-related COPD; to date, no clinical trials have focused specifically on treatment of biomass-related COPD. This study proposes to assess the health impact of biomass-related COPD and test the effectiveness of low dose theophylline compared to standard therapy among adults with biomass-related COPD in Uganda with the aim to assess whether low-dose theophylline improves respiratory symptoms, decreases the inflammatory profile of serum biomarkers and whether administration attenuates the effect of HAP on lung function. The study additionally aims to assess whether low-dose theophylline is a cost-effective intervention based on the incremental cost-effectiveness ratio and a range of willingness to pay thresholds.

NCT ID: NCT03984071 Completed - Clinical trials for ST Elevation Myocardial Infarction

The Predictive Value of eGFR for Adverse Cardiovascular Events in Patients With STEMI

Start date: October 1, 2015
Phase:
Study type: Observational

Estimated glomerular filtration rate(eGFR) is significantly reduced in patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study is to research that the incidence of adverse cardiovascular events (MACE) in patients with ST-segment elevation myocardial infarction is significantly higher when the glomerular filtration rate below a certain value.

NCT ID: NCT03983018 Completed - Clinical trials for Schizophrenia Spectrum and Other Psychotic Disorders

Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019)

Start date: August 7, 2019
Phase: Phase 1
Study type: Interventional

This study evaluates the addition of rituximab to 12 patients diagnosed with treatment resistant schizophrenia spectrum disorder in an open trial.

NCT ID: NCT03982979 Completed - Clinical trials for Advanced Refractory Left Ventricular Heart Failure

MOMENTUM 3 Pivotal Cohort Extended Follow-up PAS

Start date: June 20, 2019
Phase:
Study type: Observational

The study will be a prospective, multi-center, non-blinded, controlled study, intended to evaluate the extended use of the HM3 LVAS compared to the HMII LVAS in those patients that are ongoing at the 2-year follow-up in the MOMENTUM 3 IDE trial. A total of 1028 subjects were enrolled in the MOMENTUM 3 IDE trial. Approximately 533 subjects were ongoing support at the 2-year follow-up and are eligible for enrollment in this PAS. This study will be conducted at sites that participated in the MOMENTUM 3 IDE trial which will include up to 69 centers in the United States.

NCT ID: NCT03982901 Completed - Clinical trials for Non-Obstructive Coronary Atherosclerosis

Effect of Mental Stress on Myocardial Perfusion in Women

MS in women
Start date: June 18, 2019
Phase: N/A
Study type: Interventional

Mental stress-induced myocardial ischemia(MSIMI) has been recognized a significant clinical problem. Evidence has shown that individuals with MSIMI have 2 to 2.5 times higher risk to develop a major averse cardiovascular events over 3-5 years, compared to their counterparts who have no MSIMI. Nevertheless, investigations into the study of MSIMI among women who have chest pain but artery stenosis < 50% have been lacking. In this project, the investigators used positron emission tomography (PET) to evaluate perfusion defect during mental stress to diagnose MSIMI. Women with chest pain and coronary artery stenosis < 50% were included as the experimental group, age-matched healthy people as the control group, the aim of this study is to compare the incidence of MSIMI in the two groups. At the same time, the study also observe the change of MBF during mental stress and the relationship between MBF and MSIMI.

NCT ID: NCT03982472 Completed - Heart Rate Clinical Trials

TENS Impact Heart Rate Via Vagus Activity

Start date: July 22, 2017
Phase: N/A
Study type: Interventional

Transcutaneous electric nerve stimulation (TENS) is widely used for the treatment of adhesive capsulitis, nevertheless, its potential impact on heart physiology has not been well established. The investigator explored if TENS at shoulder region affect heart rhythm and the machinery involved. Subjects were stratified into groups received sham stimulation (TENS-S) and TENS on either the right (TENS-R) or left (TENS-L) shoulder. A built-in waveform for treating adhesive capsulitis with a maximal tolerable intensity below the pain threshold was applied to subjects form a commercial TENS equipment for 5 min. The electrocardiogram (ECG) and heart rate (HR) were continuously recorded and the ECG was off-line transferred into power spectrum for analysis.